259 related articles for article (PubMed ID: 25742642)
1. Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
Chin LH; Hsu SP; Zhong WB; Liang YC
PLoS One; 2015; 10(3):e0118674. PubMed ID: 25742642
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
Chin LH; Hsu SP; Zhong WB; Liang YC
Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758
[TBL] [Abstract][Full Text] [Related]
3. A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model.
Zhong WB; Tsai YC; Chin LH; Tseng JH; Tang LW; Horng S; Fan YC; Hsu SP
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932104
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.
Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
[TBL] [Abstract][Full Text] [Related]
5. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H
Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075
[TBL] [Abstract][Full Text] [Related]
6. PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.
Kwon EJ; Park EJ; Choi S; Kim SR; Cho M; Kim J
Int J Rheum Dis; 2017 Oct; 20(10):1499-1509. PubMed ID: 27456070
[TBL] [Abstract][Full Text] [Related]
7. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.
Xue L; Su D; Li D; Gao W; Yuan R; Pang W
Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.
Han S; Bui NT; Ho MT; Kim YM; Cho M; Shin DB
Cancer Res Treat; 2016 Jul; 48(3):1141-53. PubMed ID: 26693911
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.
Park JW; Zarnegar R; Kanauchi H; Wong MG; Hyun WC; Ginzinger DG; Lobo M; Cotter P; Duh QY; Clark OH
Thyroid; 2005 Mar; 15(3):222-31. PubMed ID: 15785241
[TBL] [Abstract][Full Text] [Related]
10. Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.
Hou CH; Lin FL; Hou SM; Liu JF
Mol Cancer; 2014 Oct; 13():236. PubMed ID: 25326651
[TBL] [Abstract][Full Text] [Related]
11. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
14. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
[TBL] [Abstract][Full Text] [Related]
15. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells.
Motomura W; Tanno S; Takahashi N; Nagamine M; Fukuda M; Kohgo Y; Okumura T
Biochem Biophys Res Commun; 2005 Jun; 332(1):89-94. PubMed ID: 15896303
[TBL] [Abstract][Full Text] [Related]
16. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
17. Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone.
Yao CJ; Lai GM; Chan CF; Cheng AL; Yang YY; Chuang SE
Int J Cancer; 2006 Feb; 118(3):773-9. PubMed ID: 16094629
[TBL] [Abstract][Full Text] [Related]
18. [Troglitazone sensitizes effect of epirubicin on breast cancer cells].
Sun JX; Meng ZX; Lv JH; Sun YJ
Ai Zheng; 2006 Aug; 25(8):960-6. PubMed ID: 16965675
[TBL] [Abstract][Full Text] [Related]
19. Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells.
Chuang JY; Yu NY; Chiang IP; Lai CH; Lin CD; Tang CH
J Cell Biochem; 2012 Jun; 113(6):1977-86. PubMed ID: 22253074
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells.
Kumei S; Motomura W; Yoshizaki T; Takakusaki K; Okumura T
Biochem Biophys Res Commun; 2009 Mar; 380(3):614-9. PubMed ID: 19285010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]